The paradoxical relationship between serum uric acid and cardiovascular disease

被引:191
作者
Lippi, Giuseppe [1 ]
Montagnana, Martina [1 ]
Franchini, Massimo [2 ]
Favaloro, Emmanuel J. [3 ]
Targher, Giovanni [4 ]
机构
[1] Univ Verona, Sez Chim Clin, Dipartimento Sci Biomed & Morfol, I-37100 Verona, Italy
[2] Azienda Osped Verona, Ctr Emofilia, Serv Immunoematol & Transfus, Verona, Italy
[3] Westmead Hosp, ICPMR, Dept Haematol, Westmead, NSW 2145, Australia
[4] Univ Verona, Sez Endocrinol, Dipartimento Sci Biomed & Chirurg, I-37100 Verona, Italy
关键词
cardiovascular disease; chronic heart failure; oxidation; risk; uric acid;
D O I
10.1016/j.cca.2008.02.024
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Uric acid (urate), an organic compound comprised of carbon, nitrogen, oxygen and hydrogen, is the final oxidation product of purine catabolism in humans, higher primates and in a particular species of dog (Dalmatians). For decades it has been hypothesized that the antioxidant properties of uric acid might be protective against aging, oxidative stress, and oxidative cell injury. However, recent epidemiological and clinical evidences suggest that hyperuricaemia might be a risk factor for cardiovascular disease, where enhanced oxidative stress plays an important pathophysiological role. It has also been hypothesized that that hyperuricaemia might be involved in chronic heart failure and metabolic syndrome. The apparent paradox between protective and toxic effects is supported by clinical evidences that antioxidant compounds may become pro-oxidant compounds in certain situations, particularly when they are present in blood at supranormal levels. The aim of this article is to review uric acid metabolism and physiology, highlighting its association with cardiovascular disease. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 139 条
[1]
Recent concepts in non-alcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P .
DIABETIC MEDICINE, 2005, 22 (09) :1129-1133
[2]
Uric acid: role in cardiovascular disease and effects of losartan [J].
Alderman, M ;
Aiyer, KJV .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) :369-379
[3]
URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].
AMES, BN ;
CATHCART, R ;
SCHWIERS, E ;
HOCHSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862
[4]
Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure [J].
Anker, SD ;
Leyva, F ;
PooleWilson, PA ;
Kox, WJ ;
Stevenson, JC ;
Coats, AJS .
HEART, 1997, 78 (01) :39-43
[5]
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions [J].
Athyros, VG ;
Ganotakis, ES ;
Elisaf, M ;
Mikhailidis, DP .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) :1157-1159
[6]
When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid [J].
Bagnati, M ;
Perugini, C ;
Cau, C ;
Bordone, R ;
Albano, E ;
Bellomo, G .
BIOCHEMICAL JOURNAL, 1999, 340 :143-152
[7]
SERUM URIC-ACID AND CORONARY HEART-DISEASE [J].
BEARD, JT .
AMERICAN HEART JOURNAL, 1983, 106 (02) :397-400
[8]
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease [J].
Bickel, C ;
Rupprecht, HJ ;
Blankenberg, S ;
Rippin, G ;
Hafner, G ;
Daunhauer, A ;
Hofmann, KP ;
Meyer, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (01) :12-17
[9]
Bonora E, 1996, INT J OBESITY, V20, P975
[10]
Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649